Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rimonabant (Acomplia) for obesity in adults with Prader-Willi syndrome
2007-006305-25Phase 2Terminated
- Sponsor
- Karolinska University Hospital
- Start
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of rimonabant in Prader-Willi syndrome (PWS) and obesity, sponsored by Karolinska University Hospital. Primary endpoint: Body weight. Started Jan 2008; status: terminated.
02
Drugs
rimonabant
03
Conditions
Prader-Willi syndrome (PWS)obesity
Beyond the preview
Go deeper on 2007-006305-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-006305-25.